Mylan, Lupin Announce Positive CHMP Opinion for Nepexto Medical Dialogues Bureau29 March 2020 8:02 AM GMTHertfordshire, Pittsburgh, and Mumbai: Mylan N.V. and Lupin Limited (Lupin) has announced that the European Medicines Agency's Committee for Medicinal...
NPPA directs 3 pharma cos to maintain stock of atleast 2.2 crore tablets of FDC Lopinavir and Ritoavir Medical Dialogues Bureau29 March 2020 7:49 AM GMTNew Delhi: The National Pharmaceuticals Pricing Authority (NPPA), Department of Pharmaceuticals directed 3 major manufacturers of the HIV Combo...
Mylan, Pfizer Upjohn merger gets delayed in light on coronavirus Medical Dialogues Bureau28 March 2020 8:00 AM GMTHertfordshire & Pittsburgh: Mylan N.V. and Pfizer Inc. today announced that due to the unprecedented circumstances surrounding the COVID-19...
Biocon, Mylan win patent rights for Insulin Glargine Device against Sanofi Medical Dialogues Bureau12 March 2020 5:59 AM GMTInsulin Glargine is a long-acting insulin used to treat adults with Type 2 diabetes and adults and paediatric patients with Type 1 diabetes for the...
USFDA Accepts Biocon, Mylan's application for review of Proposed Biosimilar of Bevacizumab Medical Dialogues Bureau10 March 2020 7:45 AM GMTBiocon Ltd. and Mylan N.V. announced that the U.S. Food and Drug Administration (FDA) has accepted Mylan's Biologics License Application (BLA)...
Mylan warns of possible drug shortages, financial hit due to coronavirus Medical Dialogues Bureau29 Feb 2020 4:00 AM GMTAlthough heavily reliant on China, the company said it was better positioned against the impact of the outbreak compared to its peers due to its...
Sanjeev Narula CFO Pfizer Upjohn appointed as incoming CFO of Viatris Medical Dialogues Bureau28 Feb 2020 8:15 AM GMTViatris is the new company that will result from the planned combination of Mylan and Upjohn
FIRST: Mylan, Micro Labs get USFDA nod for generic version of blood thinner Eliquis Medical Dialogues Bureau24 Dec 2019 4:15 AM GMTSales of Eliquis, which Bristol-Myers co-developed with Pfizer, rose 22% to $1.93 billion and made up about 30% of the Bristol-Myers' total revenues...
Mylan, Pfizer say Mylan-Upjohn combined entity to be known as Viatris Medical Dialogues Bureau16 Nov 2019 3:50 AM GMTNew Delhi: Mylan N.V. and Pfizer Inc. recently announced that the name of the new company to be formed by the planned combination of Mylan and Upjohn,...
NPPA fixes retail price of 14 drug formulations; Details Farhat Nasim13 Nov 2019 5:53 AM GMTNew Delhi: Through a recent notification, the apex drug price regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the...
Novartis gets U.S. nod for long-delayed copycat version of Amgen billion seller Neulasta drug Medical Dialogues Bureau6 Nov 2019 5:02 AM GMTZURICH: Novartis on Tuesday won U.S. approval for its long-delayed version of Amgen's $4 billion seller Neulasta drug, helping the Swiss drugmaker in...
Pfizer cancer drug Ibrance higher sales beat Q3 profit estimates Medical Dialogues Bureau30 Oct 2019 4:00 AM GMTPfizer said it expects to earn between $2.94 per share and $3.00 per share, up from a prior estimate of $2.76 to $2.86. Analysts on average were...
